Barbara Metch

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

Glenda Gray, Mary Allen, Zoe Moodie et al. · The Lancet Infectious Diseases · 2011 · 382 citations · Full text

Vaccination, Hvtn 503/Phambili, Human Retrovirus +9

Primary Tubal Infertility in Relation to the Use of an Intrauterine Device

Janet R. Daling, Noel S. Weiss, Barbara Metch et al. · New England Journal of Medicine · 1985 · 211 citations

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Spyros A. Kalams, Scott Parker, Marnie Elizaga et al. · The Journal of Infectious Diseases · 2013 · 193 citations · Full text

Determinants of Enrollment in a Preventive HIV Vaccine Trial

Susan Buchbinder, Barbara Metch, Sarah Holte et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 164 citations

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

Glenda Gray, Zoe Moodie, Barbara Metch et al. · The Lancet Infectious Diseases · 2014 · 119 citations · Full text

Vaccination, Vaccine Development, Phase 2B +9